REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 187 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $50,743 | -99.8% | 4,424 | -99.6% | 0.00% | -100.0% |
Q2 2023 | $28,634,746 | -42.2% | 1,131,361 | -26.4% | 0.05% | -43.9% |
Q1 2023 | $49,514,822 | +145.1% | 1,537,250 | +40.4% | 0.08% | +141.2% |
Q4 2022 | $20,204,912 | +27.7% | 1,094,524 | +86.7% | 0.03% | +21.4% |
Q3 2022 | $15,828,000 | +316460.0% | 586,275 | +151392.2% | 0.03% | – |
Q2 2022 | $5,000 | -87.2% | 387 | -80.7% | 0.00% | – |
Q1 2022 | $39,000 | +30.0% | 2,005 | +6.9% | 0.00% | – |
Q4 2021 | $30,000 | – | 1,875 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |